Cross-cultural adaptation and validation of the 3D-CAM Chinese version in surgical ICU patients.
- Published in:
- BMC Psychiatry, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12888-020-02544-w
- By:
- Publication type:
- Article
Works matching AU Liu, Mei-Jing
Results: 8
1
2
Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification.
- Published in:
- 2024
- By:
- Publication type:
- Letter
3
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00837-3
- By:
- Publication type:
- Article
4
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL.
- Published in:
- 2023
- By:
- Publication type:
- Letter
5
Safe and potent anti‐CD19 CAR T‐cells with shRNA‐IL‐6 gene silencing element in patients with refractory or relapsed B‐cell acute lymphoblastic leukemia.
- Published in:
- HemaSphere, 2024, v. 8, n. 10, p. 1, doi. 10.1002/hem3.70007
- By:
- Publication type:
- Article
6
Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia.
- Published in:
- HemaSphere, 2024, v. 8, n. 2, p. 1, doi. 10.1002/hem3.49
- By:
- Publication type:
- Article
7
Clinical outcomes and safety of CAR-T cells in treatment of T-Cell acute lymphoblastic leukemia/lymphoma.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 57, doi. 10.1007/s00277-024-06132-w
- By:
- Publication type:
- Article
8
Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy.
- Published in:
- Oncology Letters, 2021, v. 22, n. 5, p. N.PAG, doi. 10.3892/ol.2021.13049
- By:
- Publication type:
- Article